IMC Chicago’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.62M Sell
28,700
-2,500
-8% -$486K ﹤0.01% 1691
2025
Q4
$5.41M Buy
31,200
+10,500
+51% +$1.91M ﹤0.01% 1680
2025
Q3
$3.95M Buy
20,700
+5,700
+38% +$1.01M ﹤0.01% 1741
2025
Q2
$2.69M Sell
15,000
-2,800
-16% -$486K ﹤0.01% 1799
2025
Q1
$3.01M Buy
+17,800
New +$2.92M ﹤0.01% 1526
2024
Q4
Sell
-13,600
Closed -$2.11M 3186
2024
Q3
$2.11M Buy
+13,600
New +$2.03M ﹤0.01% 1629

Other funds holding DGX

IMC Chicago's DGX Position: Q1 2026 in Review

IMC Chicago opened a new position in Quest Diagnostics (DGX) in Q1 2026: 5,227 shares worth $1.02M. The stake represents ﹤0.01% of the portfolio and ranks #3255 among its holdings.

1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • IMC Chicago held 5,227 shares of Quest Diagnostics worth $1.02M as of Q1 2026.
  • Quest Diagnostics was a new IMC Chicago position in Q1 2026.
  • Quest Diagnostics made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3255 holding.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.